Farms.com Home   News

Arkansas Farmers to Drop Acreage in Four Major Crops in Favor of Soybeans for 2026

By Ryan McGeeney

Arkansas farmers plan to reduce planted acreage for four of the state’s five major crops, including corn, cotton, peanuts and rice, in favor of soybeans during the 2026 planting season, according to the U.S. Department of Agriculture.

Planned acreage for four of the state’s major commodity crops fell between 10 and 27 percent, while soybean acres rose 20 percent, according to the report. Planned Arkansas wheat acres remained unchanged from 2025, remaining at 110,000 acres. 

The 2026 Prospective Plantings Report from the USDA National Agricultural Statistics Service gathered data from approximately 73,800 growers across the country during a March agricultural survey. The annual report is considered a bellwether of both commodity market conditions and farmers’ outlook. 

Scott Stiles, extension agricultural economist for the University of Arkansas System Division of Agriculture, said that overall, the survey results “had every crop moving in the expected direction.” 

“For certain, there has been a clear indication for some time that there would be a sizeable increase in soybean acres and a sharp reduction in rice and cotton,” Stiles said. “Corn direction was a little more uncertain.”  

Stiles noted the importance of the timing of USDA’s survey efforts for the report, which took place from Feb. 27 through March 17, given the military incursion into Iran in late February.

Source : uada.edu

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.